• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-甲基-D-天冬氨酸受体与阿尔茨海默病

N-methyl-D-aspartate receptors and Alzheimer's disease.

作者信息

Cotman C W, Geddes J W, Bridges R J, Monaghan D T

机构信息

Department of Psychobiology, University of California, Irvine 92717.

出版信息

Neurobiol Aging. 1989 Sep-Oct;10(5):603-5; discussion 618-20. doi: 10.1016/0197-4580(89)90144-9.

DOI:10.1016/0197-4580(89)90144-9
PMID:2572983
Abstract

The results of several studies now suggest that the density of N-methyl-D-aspartate (NMDA) receptors is maintained in many Alzheimer's disease (AD) cases, although loss of these receptors can occur in specific regions as a consequence of severe neuronal loss. Recent findings demonstrate that there are at least two subtypes of the NMDA receptor which are allosterically regulated. To determine the status of the NMDA receptor in AD, studies are required which will examine the activation state of the NMDA receptor and the properties of subtypes in relation to neuronal density and structure.

摘要

现在多项研究结果表明,在许多阿尔茨海默病(AD)病例中,N-甲基-D-天冬氨酸(NMDA)受体的密度得以维持,尽管由于严重的神经元丢失,这些受体在特定区域可能会出现丢失。最近的研究发现表明,NMDA受体至少有两种亚型,它们受到变构调节。为了确定AD中NMDA受体的状态,需要开展相关研究,以检查NMDA受体的激活状态以及各亚型与神经元密度和结构相关的特性。

相似文献

1
N-methyl-D-aspartate receptors and Alzheimer's disease.N-甲基-D-天冬氨酸受体与阿尔茨海默病
Neurobiol Aging. 1989 Sep-Oct;10(5):603-5; discussion 618-20. doi: 10.1016/0197-4580(89)90144-9.
2
The role of neuronal energy in the neurotoxicity of excitatory amino acids.神经元能量在兴奋性氨基酸神经毒性中的作用。
Neurobiol Aging. 1989 Sep-Oct;10(5):611-3; discussion 618-20. doi: 10.1016/0197-4580(89)90149-8.
3
Selectivity of excitotoxic mechanisms in Alzheimer's disease.阿尔茨海默病中兴奋性毒性机制的选择性
Neurobiol Aging. 1989 Sep-Oct;10(5):606-8; discussion 618-20. doi: 10.1016/0197-4580(89)90146-2.
4
Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease.阿尔茨海默病患者中甘氨酸依赖性放射性配体与 N-甲基-D-天冬氨酸-苯环己哌啶受体复合物结合的丧失。
Neurosci Lett. 1989 Jun 5;101(1):62-6. doi: 10.1016/0304-3940(89)90441-2.
5
Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease.阿尔茨海默病患者人海马中N-甲基-D-天冬氨酸受体的密度与分布
Brain Res. 1986 Dec 3;399(1):156-61. doi: 10.1016/0006-8993(86)90611-6.
6
[3H]TCP binding sites in Alzheimer's disease.阿尔茨海默病中的[3H]TCP结合位点。
Neurosci Lett. 1987 Jan 14;73(2):197-200. doi: 10.1016/0304-3940(87)90017-6.
7
Regional changes in [3H]D-aspartate and [3H]TCP binding sites in Alzheimer's disease brains.阿尔茨海默病大脑中[3H]D-天冬氨酸和[3H]TCP结合位点的区域变化。
Brain Res. 1988 Oct 11;462(1):76-82. doi: 10.1016/0006-8993(88)90587-2.
8
The competitive NMDA receptor antagonist, CPP, allosterically modulates NMDA receptor associated PCP binding sites in the absence of steric hinderance.竞争性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂CPP在没有空间位阻的情况下变构调节与NMDA受体相关的苯环己哌啶(PCP)结合位点。
NIDA Res Monogr. 1990;105:339-40.
9
Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.阿尔茨海默病中突触前和突触后谷氨酸能功能
Neurosci Lett. 1988 Mar 21;86(1):109-13. doi: 10.1016/0304-3940(88)90192-9.
10
Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.阿尔茨海默病中突触前和突触后谷氨酸能功能的区域分布
Brain Res. 1988 Jun 14;452(1-2):403-7. doi: 10.1016/0006-8993(88)90048-0.

引用本文的文献

1
Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease.在阿尔茨海默病小鼠模型中,长期给予氟乙基去甲美金刚(FENM)的神经保护作用。
Alzheimers Res Ther. 2025 Jan 6;17(1):7. doi: 10.1186/s13195-024-01648-9.
2
Glial cell reactivity and oxidative stress prevention in Alzheimer's disease mice model by an optimized NMDA receptor antagonist.通过优化的 NMDA 受体拮抗剂预防阿尔茨海默病小鼠模型中的神经胶质细胞反应和氧化应激。
Sci Rep. 2022 Oct 25;12(1):17908. doi: 10.1038/s41598-022-22963-x.
3
CircGRIA1 shows an age-related increase in male macaque brain and regulates synaptic plasticity and synaptogenesis.
CircGRIA1 在雄性猕猴大脑中表现出与年龄相关的增加,并且调节突触可塑性和突触发生。
Nat Commun. 2020 Jul 17;11(1):3594. doi: 10.1038/s41467-020-17435-7.
4
Alteration in NMDA Receptor Mediated Glutamatergic Neurotransmission in the Hippocampus During Senescence.衰老过程中海马 NMDA 受体介导的谷氨酸能神经传递的改变。
Neurochem Res. 2019 Jan;44(1):38-48. doi: 10.1007/s11064-018-2634-4. Epub 2018 Sep 12.
5
3T hippocampal glutamate-glutamine complex reflects verbal memory decline in aging.3T海马谷氨酸-谷氨酰胺复合体反映了衰老过程中的言语记忆衰退。
Neurobiol Aging. 2017 Jun;54:103-111. doi: 10.1016/j.neurobiolaging.2017.01.026. Epub 2017 Mar 18.
6
NMDA Receptor Function During Senescence: Implication on Cognitive Performance.衰老过程中的NMDA受体功能:对认知表现的影响
Front Neurosci. 2015 Dec 16;9:473. doi: 10.3389/fnins.2015.00473. eCollection 2015.
7
The role of adenosine in Alzheimer's disease.腺苷在阿尔茨海默病中的作用。
Curr Neuropharmacol. 2009 Sep;7(3):207-16. doi: 10.2174/157015909789152119.
8
Intracerebroventricular administration of ouabain to rats changes the expression of NMDA receptor subunits in cerebral cortex and hippocampus.向大鼠脑室内注射哇巴因会改变大脑皮层和海马体中NMDA受体亚基的表达。
Neurochem Res. 2009 Sep;34(9):1650-7. doi: 10.1007/s11064-009-9956-1. Epub 2009 Mar 26.
9
The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.钠钾ATP酶抑制剂内巴因E的给药可使大脑皮层和海马体中NMDA受体亚基的表达出现不同程度的增加。
Neurochem Res. 2008 Jan;33(1):66-72. doi: 10.1007/s11064-007-9412-z. Epub 2007 Aug 8.
10
Glutamate: its role in learning, memory, and the aging brain.谷氨酸:其在学习、记忆及衰老大脑中的作用。
Psychopharmacology (Berl). 1993;111(4):391-401. doi: 10.1007/BF02253527.